Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Spain +1
  • Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Germany The Netherlands Poland Spain
  • A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Poland Spain
  • A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Bulgaria Czechia Germany Poland Spain
  • A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Germany Hungary Poland Romania
  • A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Germany Greece Poland Spain
  • A Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Czechia France Germany Greece Hungary Italy +3
  • A Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    France Germany Ireland Italy Poland Spain
  • Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

    Recruiting

    3 1 1
    Austria Belgium Bulgaria Czechia Denmark France +7
  • Study on Botulinum Toxin Type A for Treating Hidradenitis Suppurativa in Patients: A Comparison of Different Drug Combinations

    Recruiting

    3 1 1
    Investigated Diseases:
    Denmark